How Execs Plan to Use Device Tax Relief

downloadClose watchers of the medical device industry are wondering what the two-year suspension of the medical device excise tax really means in practical terms. What will come of the purported millions of dollars medtech companies are expected to save? Will device executives deploy that capital to hire more professionals, bolster their R&D teams, and encourage new inventions? Or will they drop the savings to the bottom line to satisfy the always-hungry shareholders and investor community?

A few executives at top medical device companies anticipated that question and came to this week’s J.P. Morgan Healthcare Conference in San Francisco prepared to answer it.


About Peter Coffaro 1102 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.